Thrombopoietin and thrombin induce tyrosine phosphorylation of Vav in human blood platelets

Blood

Volumn 89, Issue 8, 1997, Pages 2789-2798

  Miyakawa, Yoshitaka ^b   Oda, Atsushi ^a   Druker, Brian J ^b   Ozaki, Katsutoshi ^b   Handa, Makoto ^b   Ohashi, Hideya ^b   Ikeda, Yasuo ^b  

^a KEIO UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; CALCIUM ION; CALPAIN; COLLAGEN; GENE PRODUCT; IONOMYCIN; ONCOPROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; THROMBIN; THROMBOPOIETIN; TYROSINE;

ARTICLE; CONTROLLED STUDY; CYTOSKELETON; HUMAN; HUMAN CELL; MEGAKARYOPOIESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; THROMBOCYTE AGGREGATION; THROMBOCYTOPOIESIS;

EID: 0030945262     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.8.2789     Document Type: Article

References (66)

1. Kaushansky K: Thrombopoietin: The primary regulator of platelet production. Blood 86:419, 1995
2. Miyakawa Y, Oda A, Druker BJ, Kato T, Miyazaki H, Handa M, Ikeda Y: Recombinant thrombopoietin induces rapid protein tyrosine phosphorylation of Janus kinase 2 and Shc in human blood platelets. Blood 86:23, 1995
3. Miyakawa Y, Oda A, Druker BJ, Miyazaki H, Handa M, Ohasi H, Ikeda Y: Thrombopoietin induces tyrosine phosphorylation of Stat3 and Stat5 in human blood platelets. Blood 87:439, 1996
4. c-cbl is present in human blood platelets and is differentially involved in signaling by thrombopoietin and thrombin. Blood 88:1330, 1996
5. Oda A, Miyakawa Y, Druker BJ, Ozaki K, Yabsuaski K, Shirasawa Y, Handa M, Kato T, Miyazaki H, Ikeda Y: Thrombopoietin primes human platelet aggregation induced by shear stress and by multiple agonists. Blood 87:4664, 1996
6. Chen J, Herceg-Harjacek L, Groopman JE, Grabarek J: Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin. Blood 86:4054, 1995
7. Ezumi Y, Takayama H, Okuma M: Thrombopoietin, c-Mpl ligand, induces tyrosine phosphorylation of Tyk2, JAK-2, and STAT3, and enhances agonists-induced aggregation in platelets in vitro. FEBS Lett 374:48, 1995
8. Kojima H, Hamazaki Y, Nagata Y, Todokoro K, Nagasawa T, Abe T: Modulation of platelet activation in vitro by thrombopoietin. Thromb Haemost 74:1541, 1995
9. Montrucchio G, Brizzi MF, Calosso G, Marengo S, Pegoraro L, Camussi G: Effects of human megakaryocyte growth and development factor on platelet activation. Blood 87:2762, 1996
10. Alai M, Mui AL, Cutler RL, Bustelo XR, Barbacid M, Krystal G: Steel factor stimulates the tyrosine phosphorylation of the proto-oncogene product, p95vav, in human hemopoietic cells. J Biol Chem 267:18021, 1992
11. Hanazono Y, Sasaki K, Odai H, Mimura T, Mitani K, Yazaki Y, Hirai H: Tyrosine phosphorylation of the proto-oncogene product Vav and its association with the adapter Grb2/Ash in a human leukemia cell line UT-7. Jpn J Cancer Res 86:336, 1995
12. Matsuguchi T, Inhom RC, Carlesso N, Xu G, Druker B, Griffin JD: Tyrosine phosphorylation of p95Vav in myeloid cells is regulated by GM-CSF, IL-3 and steel factor and is constitutively increased by p210BCR/ABL. EMBO J 14:257, 1995
13. Evans GA, Howard OM, Erwin R, Farrar WL: Interleukin-2 induces tyrosine phosphorylation of the vav proto-oncogene product in human T cells: Lack of requirement for the tyrosine kinase lck. Biochem J 294:339, 1993
14. Platanias LC, Sweet ME: Interferon alpha induces rapid tyrosine phosphorylation of the vav proto-oncogene product in hematopoietic cells. J Biol Chem 269:3143, 1994
15. Clevenger CV, Ngo W, Sokol DL, Luger SM, Gewirtz AM: Vav is necessary for prolactin-stimulated proliferation and is translocated into the nucleus of a T-cell line. J Biol Chem 270:13246, 1995
16. Dosil M, Wang S, Lemischka IR: Mitogenic signalling and substrate specificity of the Flk2/Flt3 receptor tyrosine kinase in fibroblasts and interleukin 3-dependent hematopoietic cells. Mol Cell Biol 13:6572, 1993
17. Zhang R, Tsai FY, Orkin SH: Hematopoietic development of vav-/-mouse embryonic stem cells. Proc Natl Acad Sci USA 91:12755, 1994
18. Zmuidzinas A, Fischer KD, Lira SA, Forrester L, Bryant S, Bernstein A, Barbacid M: The vav proto-oncogene is required early in embryogenesis but not for hematopoietic development in vitro. EMBO J 14:1, 1995
19. Wulf GM, Adra CN, Lim B: Inhibition of hematopoietic development from embryonic stem cells by antisense vav RNA. EMBO J 12:5065, 1993
20. Katzav S: vav: A molecule for all haemopoiesis? Br J Haematol 81:141, 1992
21. Luger SM, Ratajczak J, Ratajczak MZ, Kucznsky WI, Di-Paola RS, Ngo W, Clevenger CV, Gewirtz AM: A functional analysis of protooncogene vav's role in adult human hematopoiesis. Blood 87:1326, 1996
22. Tarakhovsky A, Turner M, Schaal S, Mee PJ, Duddy LP, Rajewsky K, Tybulewicz VL: Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 374:467, 1995
23. Zhang R, Alt FW, Davidson L, Orkin SH, Swat W: Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 374:470, 1995
24. + thymocytes. Nature 374:474, 1995
25. Seiss W: Molecular mechanism of platelet activation. Physiol Rev 12:71, 1989
26. Fox JEB: Transmembrane signaling across the platelet integrin glycoprotein IIb-IIIa. Ann NY Acad Sci 714:75, 1994
27. Suzuki K, Saido TC, Hirai S: Modulation of cellular signals by calpain. Ann NY Acad Sci 674:218, 1992
28. Oda A, Druker BJ, Ariyoshi H, Smith M, Salzman EW: pp60src is an endogenous substrate for calpain in human blood platelets. J Biol Chem 268:12603, 1993
29. Frangioni JV, Oda A, Smith M, Salzman EW, Neel, BG: Calpain-catalyzed cleavage and subcellular relocation of protein phosphotyrosine phosphatase 1B (PTP-1B) in human platelets. EMBO J 12:4843, 1993
30. Earnest JP, Santos GF, Zuebig S, Fox JEB: Dystrophin-related protein in the platelet membrane cytoskeleton. J Biol Chem 270:27259, 1995
31. Du X, Saido TC, Tsubuki S, Indig FE, Williams MJ, Ginsberg MH: Calpaia cleavage of the cytoplamic domain of the integrin β3 subunit. J Biol Chem 270:24146, 1995
32. Tsujinaka T, Kajiwara Y, Kambayashi J, Sakon M, Higuchi N, Tanaka T, Mori T: Synthesis of a new cell penetrating calpain inhibitor (calpeptin). Biochem Biophys Res Commun 153:1201, 1988
33. Wencel-Drake JD, Okita JR, Annis DS, Kunicki TJ: Activation of calpain I and hydrolysis of calpain substrates (actin-binding protein, glycoprotein Ib, and talin) are not a function of thrombin-induced platelet aggregation. Arterioscler Throrab 11:882, 1991
34. Clark EA, Brugge JS: Integrins and signal transduction pathways: The road taken. Science 268:233, 1995
35. 1 of tyrosine phosphorylation induced in platelets by thrombin or ADP. Am J Physiol 262:701, 1992
36. Oda A, Druker BJ, Smith M, Salzman EW: Association of pp60src with Triton X-100-insoluble residue in human blood platelets requires platelet aggregation and actin polymerization. J Biol Chem 267:20075, 1992
37. Dexter TM, Garland J, Scott D, Scolnick E, Metcalf D: Growth of factor-dependent hematopoietic precursor cell lines. J Exp Med 152:1036, 1980
38. Ohashi H, Maruyama K, Liu Y-C, Yoshimura A: Ligand-induced activation of chimeric receptors between the erythropoietin receptor and receptor tyrosine kinases. Proc Natl Acad Sci USA 91:158, 1994
39. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680, 1970
40. Oda A, Druker BJ, Ariyoshi H, Smith M, Salzman EW: TMB-8 and dibucaine induce tyrosine phosphorylation and dephosphorylation of a common set of proteins in platelets. Am J Physiol 269:C118, 1995
41. August A, Gibson S, Kawakami Y, Kawakami T, Mills GB, Dupont B: CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/ EMT in the human Jurkat leukemic T-cell line. Proc Natl Acad Sci USA 91:9347, 1994
42. Nel AE, Gupta S, Lee L, Ledbetter JA, Kanner SB: Ligation of the T-cell antigen receptor (TCR) induces association of hSos1, ZAP-70, phospholipase C-gamma 1, and other phosphoproteins with Grb2 and the zeta-chain of the TCR. J Biol Chem 270:18428, 1995
43. Ramos-Morales F, Druker BJ, Fischer S: Vav binds to several SH2/SH3 containing proteins in activated lymphocytes. Oncogene 9:1917, 1994
44. Ye ZS, Baltimore D: Binding of Vav to Grb2 through dimerization of Src homology 3 domains. Proc Natl Acad Sci USA 91:12629, 1994
45. Shattil SJ, Ginsberg MH, Brugge JS: Adhesive signaling in platelets. Curr Opin Cell Biol 6:695, 1994
46. Rodriguez-Linares B, Watson SP: Phosphorylation of JAK-2 in thrombin-stimulated human platelets. FEBS Lett 352:335, 1994
47. Bustelo XR, Barbacid M: Tyrosine phosphorylation of the vav proto-oncogene product in activated B cells. Science 256:1196, 1992
48. Gulbins E, Coggeshall KM, Baier G, Telford D, Langlet C, Baier-Bitterlich G, Bonnefoy-Berard N, Burn P, Wittinghofer A, Altman A: Direct stimulation of Vav guanine nucleotide exchange activity for Ras by phorbol esters and diglycerides. Mol Cell Biol 14:4749, 1994
49. Katzav S, Martin-Zanca D, Barbacid M: vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. EMBO J 8:2283, 1989
50. Katzav S, Cleveland JL, Heslop HE, Pulido D: Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential. Mol Cell Biol 11:1912, 1991
51. Coppola J, Bryant S, Koda T, Conway D, Barbacid M: Mechanism of activation of the vav protooncogene. Cell Growth Differ 2:95, 1991
52. Adams JM, Houston H, Allen J, Lints T, Harvey R: The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization. Oncogene 7:611, 1992
53. Sattler M, Dustin MA, Frank DA, Okuda K, Kaushansky K, Salgia R, Griffin JD: The thrombopoietin receptor c-Mpl activates Jak-2 and Tyk2 tyrosine kinases. Exp Hematol 23:1040, 1995
54. Sasaki K, Odai H, 56, Hanazono Y, Ueno H, Ogawa S, Langdon WY, Tanaka T, Miyagawa K, Mitani K, Yazaki Y, Hirai H: TPO/c-mpl ligand induces tyrosine phosphorylation of multiple cellular proteins including proto-oncogene products, Vav and c-Cbl, and Ras signaling molecules. Biochem Biophys Res Commun 216:338, 1995
55. Nagata Y, Todokoro K: Thrombopoietin induces activation of at least two distinct signaling pathways. FEBS Lett 377:497, 1995
56. Darby C, Geahlen RL, Schreiber AD: Stimulation of macrophage Fc gamma RIIIA activates the receptor-associated protein tyrosine kinase Syk and induces phosphorylation of multiple proteins including p95Vav and p62/GAP-associated protein. J Immunol 152:5429, 1994
57. Gulbins E, Coggeshall KM, Langlet C, Baier G, Bonnefoy-Berard N, Burn P, Wittinghofer A, Katzav S, Altman A: Activation of Ras in vitro and in intact fibroblasts by the Vav guanine nucleotide exchange protein. Mol Cell Biol 14:906, 1994
58. Nakashima S, Chatani Y, Nakamura M, Miyoshi N, Kohno M, Nozawa Y: Tyrosine phosphorylation and activation of mitogen-activated protein kinases by thrombin in human platelets: Possible involvement in late arachidonic acid release. Biochem Biophys Res Commun 198:497, 1994
59. Kramer RM, Roberts EF, Hyslop PA, Utterback BG, Hui KY, Jakubowski JA: Differential activation of cytosolic phospholipase A2 (cPLA2) by thrombin and thrombin receptor agonist peptide in human platelets. Evidence for activation of cPLA2 independent of the mitogen-activated protein kinases ERK1/2. J Biol Chem 270:14816, 1995
60. Cichowski K, Brugge JS, Brass LF: Thrombin receptor activation and integrin engagement stimulate tyrosine phopshorylation of the proto-oncogene product p95vav, in platelets. J Biol Chem 271:7544, 1996
61. Yanaga F, Poole A, Asselin J, Blake R, Schieven GL, Clark EA, Law C-L, Watson SP: Syk interacts with tyrosine-phosphorylated proteins in human platelets activated by collagen and cross-linking of the Fcγ-IIa receptor. Biochem J 311:471, 1995
62. 2+ mobilization in platelets. J Biol Chem 268:2277, 1993
63. Fujii C, Yanagi S, Sada K, Nagai K, Taniguchi T, Yamamura H: Involvement of protein-tyrosine kinase p72syk in collagen-induced signal transduction in platelets. Eur J Biochem 226:243, 1994
64. Clark EA, Shattil SJ, Ginsberg MH, Bolen J, Brugge JS: Regulation of the protein tyrosine kinase pp72syk by platelet agonists and the integrin alpha IIb beta 3. J Biol Chem 269:28859, 1994
65. Maeda H, Taniguchi T, Inazu T, Yang C, Nakagawara G, Yamamura H: Protein-tyrosine kinase p72syk is activated by thromboxane A2 mimetic U44069 in platelets. Biochem Biophys Res Commun 197:62, 1993
66. Castresana J, Saraste M: Does Vav bind to F-actin through a CH domain? FEBS Lett 374:149, 1995